Essentially, Ipamorelin is the short-term trigger for the pituitary to release growth hormone, whereas the CJC-1295 is a much longer-term trigger (with raised hormone levels for as much as 6 to 10 days after administration) The Benifits CJC1295 Increased levels of energy, and better energy metabolism, with decreased fatigue Decreased body fat More easily maintained existing muscle mass, and increased ease to gain new lean muscle mass Higher rates of cellular repair, replication, and regeneration, making it easier to heal from injuries and boosting the immune system Greater bone mineral content, which can be effective at offsetting or decreasing the risk of osteoporosis Improved sleep quality Ipamorelin Increased levels of energy, and better energy metabolism, with decreased fatigue Decreased body fat More easily maintained existing muscle mass, and increased ease to gain new lean muscle mass Higher rates of cellular repair, replication, and regeneration, making it easier to heal from injuries and boosting the immune system Greater bone mineral content, which can be effective at offsetting or decreasing the risk of osteoporosis Improved sleep quality
Metabolic and Cardiovascular Benefits By reducing systemic inflammation and improving insulin sensitivity, FOXO4-DRI supports metabolic health, lowering risks associated with type 2 diabetes and cardiovascular disease
Reconstituted IGF-1 LR3 is stable at 28C for up to 28 days, but every hour spent at room temperature accelerates degradation
This study investigated how quickly AOD9604 breaks down in blood and what products it forms when it does
